1. Al-Mefty O, Kersh JE, Routh A and Smith RR. The long-term side effects of radiation therapy for benign brain tumors in adults. J Neurosurg 1990;73:502-512.
2. Alexander L, Appleton D, Hall R, Ross WM and Wilkinson R. Epidemiology of acromegaly in the Newcastle region. Clin Endocrinol 1980;12:71-79.
3. Aloia JF, Field RA and Kramer S. Treatment of acromegaly. Arch Intern Med 1973;131:509-515.
4. Aloia JF, Roginsky MS and Archambeau JO. Pituitary irradiation in acromegaly. Am J Med Sci 1974;267:81-8 7.
5. Aristizabal S, Caldwell WL and Avila J. The relationship of time-dose fractionation factors to complications in the treatment of pituitary tumors by irradiation. Int J Radiat Oncol Biol Phys 1977;2:667-673.
6. Atkinson AB, Allen IV, Gordon DS, et al. Progressive visual failure in acromegaly following external pituirary adenoma. Clin Endocrinol 1979;10:469-479.
7. Baldwin A, Cundy T and Butler J. Progression of cardiovascular disease in acromegalic patients treated by external pituitary irradiation. Acta Endocrinologica 1985;108:26-30.
8. Barceló B, Pérez C, Dávila N, Lucas T, Salto L, Alcañiz J. Valoración endocrinológica de 61 pacientes acromegálicos tratados con cirugía transesfenoidal aislada, o asociada a telecobaltoterapia y/o bromocriptina. Med Clin 1982;80:735-741.
9. Bataini JP, Glinski B. Supervoltage irradiation in the management of pituitary adenomas.
In: Derome PJ, Jedyak CP, Peillon F, editors. Pituitary Adenomas. Paris: Asclepios Publishers, 1980. p.203.
10. Bengtsson B, Edén S, Ernest I, Odén A, Sjögren B. Epidemiology and long-term survival in acromegaly. Acta Med Scand 1988;223:327-335.
11. Bergh van den ACM, Hoving MA, Links TP, et al. Radiation optic neuropathy after external beam radiation therapy for acromegaly. Short communication. Radiother Oncol 2003;68:101-103.
12. Béclère MA. Radiotherapie, techniques, résultats, indications et contre-indications de la roentgenthérapie des tumeurs hypophysiares. Rev Neurol 1922;808-817.
13. Bloom B, Kramer S. Conventional Radiation Therapy in the Management of Acromegaly. In: McL.Black P.et al., editors. Secretory Tumors of the Pituitary Gland (progress in endocrine research and therapy), 1st ed. New York: Raven Press, 1984;179-190.
14. Borruat F-X, Schatz NJ, Glaser JS. Neuropathie optique retrobulbaire post-actinique. Klin Monatsbl Augenheilkd 1996;208:381-384.
15. Borruat F-X, Schatz NJ, Glaser JS, Feun LG, Matos L. Visual recovery from radiation-induced optic neuropathy. J Clinical Neuro-opthalmology 1993;13:98-101.
16. Bringer J, Klawatsch D, Jaffiol C, Orsetti A, Robin M, Mirouze J. Comparaison de diverses therapeutiques de l’acromegalie tumorale. Annales d’ endocrinologie 1983;44:107-114.

17. Chang CH. Radiotherapy of secretory and nonsecretory pituitary adenomas. In: Chang CH, Honaspian EM, editors. Tumours of the central nervous system: modern radiotherapy in multidisciplinary management., New York: Mason; 1982. p.201-213.
18. Ciccarelli E, Valetto MR, Vasario E, Avataneo T, Grottoli S, Camanni F. Hormonal and radiological effects of megavoltage radiotherapy in patients with growth hormone-secreting pituitary adenoma. J Endocrinol Invest 1993;16:565-572.
19. Clarke SD, Woo SY, Butler EB, et al. Treatment of secretory pituitary adenoma with radiation therapy. Radiology 1993;188:759-763.
20. Colby MY, Kearns TP. Radiation therapy of pituitary adenomas with associated visual impairment. Staff meetings of the Mayo Clinic 1962;37:15-24.
21. Cozzi R, Barausse M, Asnaghi D, Dallabonzana D, Lodrini S and Attanasio R. Failure of radiotherapy in acromegaly. Eur J Endocrinol 2001;145:717-726.
22. Davis DH, Laws ER, Ilstrup DM, et al. Results of surgical treatment for growth hormone-secreting pituitary adenomas. J Neurosurg 1993;79:70-75.
23. Dowsett RJ, Fowble B, Sergott RC, et al. Results of radiotherapy in the treatment of acromegaly: lack of ophthalmologic complications. Int J Radiat Oncol Biol Phys 1990;19:453-459.
24. Eastman RC, Gorden P, Roth J. Conventional supervoltage irradiation is an effective treatment for acromegaly. J Clin Endocrinol Metab 1978;48:931-940.
25. Eastman RC, Gordon P, Glatstein E, Roth J. Radiation therapy of acromegaly. Endocrinol Metab Clin North Am 1992;21:693-712.
26. Effenterre vR, Boch A-L. Radionécrose du chiasma, étude clinique et radiologique. A propos de trois cas. Neurochirurgie 1993;39:75-84.
27. Emmanuel IG. Symposium on Pituitary tumours (3) historical aspects of radiotherapy, present treatment technique and results. Clin Radiol 1966;17:154-160.
28. Epaminonda P, Porretti S, Vincenzo C, Beck-Peccoz P, Faglia G, Arosia, M. Efficacy of radiotherapy in normalizing serum IGF-I, acid-labile subunit (ALS) and IGFBP-3 levels in acromegaly. Clin Endocrinol 2001;55:183-189.
29. Feek CM, McLelland J, Seth J, et al. How effective is external pituitary irradiation for growth hormone-secreting pituitary tumours? Clin Endocrinol 1984;20:401-408.
30. Forrest APM, Peebles Brown DA, Morris SR, Illingworth CFW. Pituitary radon implant for advanced cancer. Lancet 1956;270:399-401.
31. Giovanelli MA, Gaini SM, Tomei G, et al. Transsphenoidal microsurgical treatment of acromegaly. In: Lamberts SWJ, Tilders FJH, van der Veen EA, Assies J, editors. Trends in diagnosis and treatment of pituitary adenomas., Amsterdam: Free University Press; 1984. p.215-224.
32. Goffman TE, Dewan R, Arakaki R, Gorden P, Oldfield EH, Glatstein E. Persistent or recurrent acromegaly. Cancer 1992;69:271-275.

33. Gorden P, Glatstein E, Oldfield EH, et al. Conventional supervoltage radiation in the treatment of acromegaly. In: Robbins RJMS, editor. Acromegaly.A century of scientific and clinical progress., New York: Kluwer/Plenum Publishers;1987. p. 211.
34. Gordon DA, Hill FM and Ezrin C. Acromegaly: A Review of 100 cases. Can Med Assoc J 1962;87:1106-1109.
35. Gramegna, A. Un cas d’acromégalie traité par la radiothérapie. Rev Neurol 1909;17:15-17.
36. Grattan-Smith PJ, Morris JG, Langlands AO. Delayed radiation necrosis of the central nervous system in patients irradiated for pituitary tumours. J Neurol Neurosurg Psychiatry 1992;55:949-955.
37. Gutt B, Hatzack C, Morrison K, Pollinger Band Schopohl J. Conventional pituitary irradiation is effective in normalising plasma IGF-I in patients with acromegaly. Eur J Endocrinol 2001;144:109-116.
38. Guy J, Mancuso A, Beck R, et al. Radiation-induced optic neuropathy: a magnetic resonance imaging study. J Neurosurg 1991;74:426-432.
39. Hammer HM. Optic Chiasmal Radionecrosis. Trans ophthal Soc U K 1983;103:208-211.
40. Hardy J, Somma M, Vezina JL. Treatment of acromegaly: radiation or surgery? In: Morley JP, editor. Current controversies in neurosurgery., New York: W.B.Saunders; 1976. p.377.
41. Harris JR, Levene MB. Visual complications following irradiation for pituitary adenomas and craniopharyngiomas. Radiology 1976;120:167-171.
42. Holdaway IM, Rajasoorya C. Epidemiology of acromegaly. Pituitary 1999;2:29-41.
43. Hughes MN, Llamas KJ, Yelland ME, Obst D, Tripcony LB. Pituitary adenomas: long-term results for radiotherapy alone and post-operative radiotherapy. Int Radiat Oncol Biol Phys 1993;27:1035-1043.
44. Hunter WM, Gillingham FJ, Harris P, et al. Serial assays of plasma growth hormone in treated and untreated acromegaly. J Endocrinol 1974;63:21-34.
45. Jenkins JS, Ash S, Bloom HJG. Endocrine function after external pituitary irradiation in patients with secreting and nonsecreting pituitary tumours. Q J Med, new series 1972; XLI:57-69.
46. Jiang GL, Tucker SL, Guttenberger R, et al. Radiation-induced injury to the visual pathway. Radiother Oncol 1994;30:17-25.
47. Kanis JA, Gillingham FJ, Harris P, et al. Clinical and laboratory study of acromegaly: assessment before and one year after treatment. Q J Med, new series 1974;XLIII:409-431.
48. Klijn JGM, Lamberts SWJ, Woerkom van-Eijkenboom WMH, et al. Long term follow-up after external pituitary irradiation of pituitary adenomas. In: Lamberts SWJ, Tilders FJH, van der Veen EA, Assies J, editors. Trends in diagnosis and treatment of pituitary adenomas., Amsterdam: Free University Press; 1984:359-372.
49. Kline LB, Kim JY, Ceballos R. Radiation optic neuropathy. Ophthalmology 1985;92:1118-1126.
50. Kozak GP, Vagnucci AI, Lauler DP, Thorn GW. Acromegaly pre- and postpituitary irradiation. Metabolism 1966;15:290-303.
51. Kramer S. Indications for, and results of, treatment of pituitary tumors by external radiation. In: Kohler PO, Ross GT, editors. Diagnosis and treatment of pituitary tumors, New York: American Elsevier Publishing Co; 1973. p.217-230.
52. Kundra SN, Sharma BS, Banerjee AK, Ayyagari S, Dhir SP, Kak VK. Damage to the anterior visual pathway and brain parenchyma following external pituitary irradiation. Indian J Cancer 1990;27:172-179.
53. Lam KSL, Wang C, Choi P, Ma JTC, Yeung RTT. Long-term effects of megavoltage radiotherapy. Aust NZ J Med 1989;19:202-206.
54. Lamberg B-A, Kivikangas V, Vartiainen J, Raitta C, Pelkonen R. Conventional pituitary irradiation in acromegaly. Acta Endocrinol 1976;82:267-281.
55. Landolt AM. Hazards of radiotherapy in patients with pituitary adenomas. In: Derome PJ, Jedyak CP, Peillon F, editors. Pituitary Adenomas. Paris: Asclepios Publishers; 1980. p.227-231.
56. Lawrence AM, Pinsky SM, Goldfine ID. Conventional radiation therapy in acromegaly. Arch Intern Med 1971;128:369-377.
57. Littley MD, Shalet SM, Swindell R, Beardwell CG, Sutton ML. Low-dose pituitary irradiation for acromegaly. Clin Endocrinol 1990;32:261-270.
58. Lüdecke DK, Lutz BS, Niedworok G. The choice of treatment after incomplete adenomectomy in acromegaly: proton- versus high voltage radiation. Acta Neurochir (Wien) 1989;96:32-38.
59. Macleod AF, Clarke DG, Pambakian H, Lowy C, Sonksen PH, Collins CD. Treatment of acromegaly by external irradiation. Clin Endocrinol 1989;30:303-314.
60. McCollough WM, Marcus RB, Rhoton AL, Ballinger WE, Million RR. Long-term follow-up of radiotherapy for pituitary adenoma: the absence of late recurrence after >4500cGy. Int J Radiat Oncol Biol Phys 1991;21:607-614.
61. Melmed S, Jackson I, Kleinberg D, Klibanski A. Current treatment guidelines for acromegaly. J Clin Endocrinol Metab 1998;83:2646-4652.
62. Millar JL, Spry NA, Lamb DS, Delahunt J. Blindness in patients after external beam irradiation for pituitary adenomas: two cases occurring after small daily fractional doses. Clin Oncol 1991;3:291-294.
63. Movsas B, Movsas TZ, Steinberg SM, Okunieff P. Long-term visual changes following pituitary irradiation. Int J Radiat Oncol Biol Phys 1995;33:599-605.
64. O’Halloran DJ, Shalet SM. Acromegaly: unravelling a complex disease. Growth Regul 1995;5:119-124.
65. Parsons JT, Bova FJ, Fitzgerald CR, Mendenhall WM, Million RR. Radiation optic neuropathy after megavoltage external-beam irradiation: analysis of time-dose factors. Int J Radiat Oncol Biol Phys 1994;30:755-764.
66. Pistenma DA, Goffinet DR, Bagshaw MA, Hanbery JW, Eltringham JR. Treatment of acromegaly with megavoltage radiation therapy. Int J Radiat Oncol Biol Phys 1976;1:885-893.

67. Powell JS, Wardlaw SL, Post KD, Freda PU. Outcome of radiotherapy for acromegaly using normalization of insulin-like growth factor I to define cure. J Clin Endocrinol Metab 2000;85:2068-2071.
68. Rivoal O, Brézin AP, Feldman-Billard S, Luton J-P. Goldmann perimetry in acromegaly. Ophthalmology 2000;107:991-997.
69. Roden D, Bosley TM, Fowble B, et al. Delayed radiation injury to the retrobulbar optic nerves and chiasm. Ophthalmology 1990;97:346-351.
70. Ross DA, Wilson CB. Results of transsphenoidal microsurgery for growth hormone-secreting pituitary adenoma in a series of 214 patients. J Neurosurg 1988;68:854-867.
71. Salinger DJ, Brady LW, Miyamoto CT. Radiation therapy in the treatment of pituitary adenomas. Am J Clin Oncol 1992;15:467-473.
72. Schatz NJ, Lichtenstein S, Corbett JJ. Delayed radiation necrosis of the optic nerves and chiasm. In: Glaser JS, Smith JL, editors. Neuro Ophthalmology Symposium of the University of Miami and the Bascom Palmer Eye Institute, 8th ed. St. Louis: CV Mosby; 1975. p.131-139.
73. Sheline GE, Goldberg MB, Feldman R. Pituitary irradiation for acromegaly. Radiology 1961;76:70-75.
74. Shih T-Y, Wei C-P, Lui C-C, Leung W. Magnetic resonance imaging of radiation necrosis after radiotherapy for acromegaly: report of a case. J Formos Med Assoc 1994;93:78-80.
75. Speirs CJ, Reed PI, Morrison R, Joplin GF. The effectiveness of external beam radiotherapy for acromegaly is not affected by previous pituitary ablative treatments. Acta Endocrinol 1990;122:559-565.
76. Thalassinos NC, Tsagarakis S, Ioannides G, Tzavara I, Papavasilou C. Megavoltage pituitary irradiation lowers but seldom leads to safe GH levels in acromegaly: a long term follow-up study. Eur J Endocrinol 1998;138:160-163.
77. Trampe af E, Lundell G, Lax I, Werner S. External irradiation of growth hormone producing pituitary adenomas: prolactin as marker of hypothalamic and pituitary effects. Int J Radiat Oncol Biol Phys 1990;20:655-660.
78. Tran LM, Blount L, Horton D, Sadeghi A, Parker RG. Radiation therapy of pituitary tumors: results in 95 cases. Am J Clin Oncol 1991;14:25-29.
79. Tsang FW, Brierley JD, Panzarella T, Gospodarowicz MK, Sutcliffe SB, Simpson WJ. Role of radiation therapy in clinically hormonally-active pituitary adenomas. Radiother Oncol 1996;41:45-53.
80. Wambersie, A. ICRU report 62; prescribing, recording and reporting photon beam therapy (Supplement to ICRU 50); 1999.
81. Wass JAH, Plowman PN, Jones AE. The treatment of acromegaly by external pituitary irradiation and drugs. In: Lüdecke DKTG, editor. Growth hormone growth factors, and acromegaly. New York: Raven Press; 1987. p.199.

82. Werder vK, Eversmann T, Fahlbusch Real. Endocrine-active pituitary adenomas: long-term results of medical and surgical treatment. In: Camanni F, Müller EE, editors. Pituitary hyperfunction: physiopathology and clinical aspects. New York: Raven Press; 1984.p.385-406.
83. Werner S, Trampe E, Palacios P, Lax I, Hall K. Growth hormone producing pituitary adenomas with concomitant hypersecretion of prolactin are particularly sensitive to photon irradiation. Int J Radiat Oncol Biol Phys 1985;11:1713-1720.
84. Zaugg M, Adaman O, Pescia R, Landolt AM. External irradiation of macroinvasive pituitary adenomas with telecobalt: a retrospective study with long-term follow-up in patients irradiated with doses mostly of between 40-50 Gy. Int J Radiat Oncol Biol Phys 1995;32:671-680.